Home
Company
Product
Regulation
China
Data
Exhibition
Interview
中文版
Home
Company
Product
Regulation
China
Data
Exhibition
Interview
中文版
Search

The U.S. Department of Justice and FDA seized 2.1 million e-cigarettes and 12 distributors and retailers were sued

Sep.30.2025
Recently, the U.S. Department of Justice and the FDA announced a joint crackdown on illegal e-cigarettes, seizing over 2.1 million unauthorized e-cigarette products from five distributors and six retailers in seven states. The companies involved had previously received warnings from the FDA but continued to sell products without market approval. This operation was jointly carried out by multiple government departments, and civil injunction lawsuits have been filed against 12 related companies an

Key points:

 

  • The US Department of Justice and FDA have conducted a joint operation, seizing 2.1 million illegal e-cigarette products across seven states. 
  • The seized e-cigarette products did not undergo FDA market review and some were found to have false labels. 
  • The Department of Justice has filed civil injunction lawsuits against the distributors and retailers involved to prevent the sale of illegal products in the future. 
  • The court has authorized the seizure of e-cigarette products that have not been approved by the FDA, ensuring that illegal products do not enter the market.

 

 

2Firsts, September 30, 2025 - According to a press release from the U.S. Department of Justice website, the Justice Department, together with the U.S. Food and Drug Administration (FDA), announced today that recent actions targeting unauthorized flavored e-cigarettes, or vapes, resulted in the seizure of more than 2.1 million illicit vaping products taken from five distributors and six retailers across seven different states.

 

In detention complaints and related court documents filed in a US district court, the government alleges that these distributors and retailers received warnings from the FDA informing them that their e-cigarettes needed to obtain premarket approval before being legally sold.

 

According to the seizure complaint, recent inspections by the FDA and undercover purchases by agents from the Alcohol, Tobacco, Firearms and Explosives Bureau (ATF) show that these companies continue to sell or distribute unauthorized e-cigarette products. The seizure operation was carried out by the US Marshals Service, ATF agents, and other law enforcement partners, with support from the Department of Health and Human Services (HHS) and the FDA.

 

Attorney General Pamela Bondi has stated that this month's raid is just the beginning, and the DOJ will be working with HHS to prosecute all individuals involved in the illegal sale of these products.

 

The Department of Justice has filed civil injunction lawsuits against distributors and retailers of seized products in an effort to prevent future illegal activities. The complaints allege that the defendants continued to sell counterfeit and falsely labeled tobacco products even after receiving warnings from the FDA.

 

The injunction lawsuit targets the detained entities and individuals, including:

 

  • A company named Tampa Vapor and its owner, Michael R. Synychak, have filed a lawsuit in central Florida against an entity.

 

  • Progressive Retail Inc., operating under the name Rainbow Food Mart, is a company based in Tampa, Florida. Its president Varun Chawla has filed a lawsuit in the central district of Florida.

 

  • Bouslimi Holdings, Inc., operating under the name Marathon/Food Center, is a company based in Tampa, Florida. Its president, Imed Bouslimi, has filed a lawsuit in central Florida.

 

  • Joint Effort, Inc. is a company based in Miami, Florida, operating under the name Blvd Smoke Shop. The company's executive and director, Husam Bahhur, has filed a lawsuit in the southern district of Florida.

 

  • Calle 8 Petroleum LLC, operating under the name UGAS/Circle K, is a company based in Miami, Florida. Its owner, Rashid A. Saeed, has filed a lawsuit in the southern district of Florida.

 

  • Smoke House Sunset is a company located in Los Angeles, California. Its owner, Ali Masoud, has filed a lawsuit in the Central District of California.

 

  • D&A Distribution, LLC conducts business under the name Strictly E-Cig and is a company headquartered in Savannah, Georgia. The owner, Robert S. Ali, has filed a lawsuit in the southern district of Georgia.

 

  • PSM101, LLC conducts business under the name Center Point Distributors, with its headquarters located in South Plainfield, New Jersey. The owner is Niravkumar G. Vora, who has filed a lawsuit in the New Jersey area.

 

  • B&G Trading LLC, operating under the name Vaportech Wholesale, is headquartered in Phoenix, Arizona. The company is co-owned by Ataman Bilgin and Hasmet Girgin, who are involved in a lawsuit in the Arizona area.

 

  • Midwest Goods Inc. operates under the names Midwest Distribution and Midwest Distribution Illinois, with its headquarters located in Bensonville, Illinois. The owner and CEO of the company is Kamran Yasin, and the company has filed a lawsuit in the northern district of Illinois.

 

  • Dream Distro LLC, a company located in Garner, North Carolina, is facing a lawsuit from its owner Faisal A. Alhadrami in the Eastern District of North Carolina.

 

  • A lawsuit has been filed against Gorilla Vapes LLC, a company based in New Jersey, and its co-owners Nick Jurczyk and Russell Jurczyk in the state of New Jersey.

 

According to the law, e-cigarette manufacturers typically must obtain FDA market review and approval before selling their products. In each seizure action, the court has issued seizure orders authorizing the confiscation of e-cigarette products that have not been granted market authorization.

 

References:
[1] More Than Two Million Illicit Vaping Products Seized in Nationwide Sweep
Also Read:
[1] U.S. CBP and FDA Seize 165,000 Illicit E-Cigarette Products; Total Value Exceeds $1.47 Million

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

China Tobacco Regulation Shift：Policy Updates and Market Impact
China Tobacco Regulation Shift：Policy Updates and Market Impact
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
At the 2026 New Approaches Summit in New York, former FDA Center for Tobacco Products Director Mitch Zeller called for the tobacco harm reduction debate to shift from the traditional “end game” toward defining a desired “end state.” He also highlighted unresolved concerns around dual use, argued that biomarkers of exposure may be more meaningful than cigarettes-per-day in assessing risk reduction, and said nicotine misperceptions remain a major barrier to public health progress.
Sep.25
South Korea Extends Vape Rules to Unmanned Stores After Bringing Synthetic Nicotine Under Tobacco Law
South Korea Extends Vape Rules to Unmanned Stores After Bringing Synthetic Nicotine Under Tobacco Law
South Korea's Ministry of Gender Equality and Family said on September 14 that it plans to designate unmanned e-cigarette stores as businesses where minors are prohibited from entering or working. Operators would be required to verify customers' ages and display notices restricting access by minors. The proposal is open for public comment through October 6. The move follows an April expansion of South Korea's statutory tobacco definition that brought products made with natural or synthetic nicotine under the Tobacco Business Act. Nicotine-free liquids and products using nicotine analogues such as 6-methylnicotine, however, remain an emerging regulatory issue.
Sep.21
NATO Executive Director David Spross Sees U.S. Vape Regulation Improving, Calls for More PMTA Authorizations and Warns of 2027 State Tax Pressure
NATO Executive Director David Spross Sees U.S. Vape Regulation Improving, Calls for More PMTA Authorizations and Warns of 2027 State Tax Pressure
The National Association of Tobacco Outlets is calling for more FDA marketing authorizations, greater transparency in the PMTA process and continued enforcement against unauthorized e-cigarettes, even as its executive director, David Spross, points to recent regulatory developments as signs of progress. At the state level, excise taxes, flavor restrictions and vapor product directories remain major issues for tobacco retailers. By August 2026, 17 states had enacted laws establishing state-managed e-cigarette directories or similar systems.
Innovation
Sep.29 by 2Firsts Perspectives
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
American Vapor Manufacturers (AVM) and Altria subsidiaries Helix Innovations and NJOY filed separate motions on October 7, 2026, seeking to intervene on the FDA's side in a lawsuit challenging its enforcement guidance for certain e-cigarette and nicotine pouch products with pending premarket tobacco product applications (PMTAs). Seven public health and tobacco-control organizations, including the Campaign for Tobacco-Free Kids, sued the agency in July to overturn the policy. AVM argues that vacating the guidance could disrupt orders, inventory, retail distribution and investments in regulatory submissions.
Regulations
Oct.09
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
FDA Unifies Tobacco Registration and Product Listing Form Across Product Categories
FDA Unifies Tobacco Registration and Product Listing Form Across Product Categories
The U.S. FDA has consolidated two tobacco establishment registration and product listing forms into a redesigned Form FDA 3741 covering all regulated product categories, including e-cigarettes, heated tobacco products and nicotine pouches. The current requirements remain limited to domestic establishments. Separately, the FDA has proposed extending registration and product listing requirements to foreign manufacturers, signaling greater regulatory attention to manufacturing entities and product-level information across the tobacco and nicotine supply chain.
FDA
Sep.30
Related Topics
HEADLINE News Regulation
Related Read
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
South Korea Extends Vape Rules to Unmanned Stores After Bringing Synthetic Nicotine Under Tobacco Law
South Korea Extends Vape Rules to Unmanned Stores After Bringing Synthetic Nicotine Under Tobacco Law
NATO Executive Director David Spross Sees U.S. Vape Regulation Improving, Calls for More PMTA Authorizations and Warns of 2027 State Tax Pressure
NATO Executive Director David Spross Sees U.S. Vape Regulation Improving, Calls for More PMTA Authorizations and Warns of 2027 State Tax Pressure
2Firsts Perspectives
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
FDA Unifies Tobacco Registration and Product Listing Form Across Product Categories
FDA Unifies Tobacco Registration and Product Listing Form Across Product Categories
FOLLOW US ON SOCIAL MEDIA
Contact: info@2firsts.com
Stay up to date.
Submit your email to receive weekly newsletter on the most relevant news of the e-cigarette industry.
© 2026 2FIRSTS. All Right Reserved.
2FIRSTS is only accessible to industry practitioners, researchers, media and other professionals. Access by minors is prohibited.
This website provides services to users outside the Chinese mainland.
English
English
中文